GlaxoSmithKline plc (LSE: GSK NYSE: GSK) is a United Kingdom-based pharmaceutical, biological, and healthcare company. GSK is the world's second largest pharmaceutical company and a research-based company with a wide portfolio of pharmaceutical products covering anti-infectives, central nervous system, respiratory, gastro-intestinal/metabolic, oncology, and vaccines products. It also has a Consumer Healthcare operation comprising leading oral healthcare products, nutritional drinks, and over the counter medicines. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index. (via Wikipedia)
Stock Symbol:
GSK
Operating Income:
£8.259 billion (2008)
Net Income:
£4.712 billion (2008)
Name:
GlaxoSmithKline
Motto:
"Do more, feel better, live longer"
Founded:
2000, by merger of Glaxo Wellcome and SmithKline Beecham
Products:
Pharmaceuticals
Central nervous system, respiratory, antiviral, antibiotic,
oncology and emesis, metabolic, cardiovascular, urogenital, and
over-the-counter medicines; vaccines; oral and nutritional
healthcare products
Type:
NYSE: GSK)
Public (LSE: GSK
No. of Employees:
103,000 (2008)
Key People:
Andrew Witty, Chief Executive
Dr. Moncef Slaoui, Chairman of Research and Development
Julian Heslop, Chief Financial Officer
Sir Chris Gent, Chairman
Revenue:
£24.352 billion (2008)
Industry:
Pharmaceutical
Website:
www.gsk.com
Location:
Brentford, London, England, UK
Category: (Book)
4 new, starting at $8.43
4 used, starting at $11.00
Category: (Health and Beauty)
1 new, starting at $24.77
Category: (Health and Beauty)
9 new, starting at $7.99
Questor share tips: Glaxo is a yield play whatever happens Advair
18 Mar 2010 19:56:45 GMT | Telegraph.co.uk - Business
UPDATE 1-Glaxo up as Novartis drops generic Advair in U.S.
18 Mar 2010 09:28:37 GMT | Reuters
GlaxoSmithKline gives FTSE 100 a lift
18 Mar 2010 13:18:40 GMT | Telegraph.co.uk - Business
Signup on GlaxoSmithKline